Here, the authors show that SETDB1 contributes to hepatocellular cancer by preferably forming a complex with mutant p53, resulting in di-methylation of a critical lysine residue and stabilization of the protein. This evidence concerns the gene SETDB1 and hepatocellular carcinoma.